ArticleJournal of experimental & clinical cancer research : CR2024

EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.

Ambra Cappelletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.